Prevalence of cervical cytological abnormalities in Turkey
dc.authorid | Kocak, Cengiz/0000-0003-3819-6822 | |
dc.authorid | Kiran, Gurkan/0000-0002-6300-328X | |
dc.authorid | guven, suleyman/0000-0003-4832-4525 | |
dc.authorid | Karaca, Mehmet/0000-0003-3219-9109 | |
dc.authorid | Mutlu, Ahmet Emin/0000-0002-5092-1364 | |
dc.contributor.author | Kara, Fadil | |
dc.contributor.author | Kiran, Guerkan | |
dc.contributor.author | Metindir, Jale | |
dc.contributor.author | Ozan, Hakan | |
dc.contributor.author | Ozalp, Sinan | |
dc.contributor.author | Vardar, M. Ali | |
dc.contributor.author | Zeren, Handan | |
dc.date.accessioned | 2024-09-18T20:08:11Z | |
dc.date.available | 2024-09-18T20:08:11Z | |
dc.date.issued | 2009 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Objective: To evaluate retrospectively the prevalence of cervical cytological abnormalities in patient records obtained from healthcare centers in Turkey. Method: Demographic characteristics and data on cervical cytological abnormalities were evaluated from patients who underwent flap tests in healthcare centers in 2007. Results: Data were collected from 33 healthcare centers totaling 140 334 patients. Overall, the prevalence of cervical cytological abnormalities was 1.8%; the prevalence of ASCUS, ASC-H, LSIL, HSIL, and AGC was 1.07%, 0.07%, 0.3%, 0.17%, and 0.08%, respectively. The prevalence of preinvasive cervical neoplasia was 1.7% and the prevalence of cytologically diagnosed invasive neoplasia was 0.06%. Conclusion: The abnormal cervical cytological prevalence rate in Turkey is lower than in Europe and North America. This might be due to sociocultural differences, lack of population-based screening programs, or a lower HPV prevalence rate in Turkey. (C) 2009 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved. | en_US |
dc.identifier.doi | 10.1016/j.ijgo.2009.04.003 | |
dc.identifier.endpage | 209 | en_US |
dc.identifier.issn | 0020-7292 | |
dc.identifier.issn | 1879-3479 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 19541303 | en_US |
dc.identifier.scopus | 2-s2.0-68349139717 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 206 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.ijgo.2009.04.003 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/8692 | |
dc.identifier.volume | 106 | en_US |
dc.identifier.wos | WOS:000269782800005 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | International Journal of Gynecology & Obstetrics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cervical cancer | en_US |
dc.subject | Cervical cytology | en_US |
dc.subject | Cervical intraepithelial neoplasias | en_US |
dc.subject | Cervical neoplasias | en_US |
dc.subject | Pap test | en_US |
dc.subject | Pap smear | en_US |
dc.subject | Turkey | en_US |
dc.title | Prevalence of cervical cytological abnormalities in Turkey | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1